In this article, we will discuss Durvalumab (Patient Counseling-4). So, let’s get started.
Endocrinopathies: Advise patients to contact their healthcare provider immediately for signs or symptoms of hypothyroidism, hyperthyroidism, adrenal insufficiency, type 1 diabetes mellitus, or
hypophysitis.